ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
R

ASCO 2022 on Telisotuzumab Vedotin in Advanced c-Met Overexpressing NSCLC: Monotherapy in Previously Treated Disease; Combination With Osimertinib After Failure on Prior Osi in EGFRm Disease

By ASCO 2022 Conference Coverage FEATURING Ross Camidge
By ASCO 2022 Conference Coverage FEATURING Ross Camidge
180 views
June 14, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

02:58
Lilly Medical Affairs

A Heterogenous Disease with Varied Clinical Outcomes: HR+/HER2- MBC

Feat. J. O’Shaughnessy

Featured Video

03:57
Lilly Medical Affairs

Resistance Mechanisms to ET, Including ESR1 Mutations in HR+, HER2- …

Feat. K. Jhaveri
Lung
01:24

Lecture Summary - ASCO 2022 Five-Year Survival Outcomes From CheckMa…

ASCO 2022 Conference Coverage

L. Paz-Ares

97 views
10:59

ASCO 2022 Five-Year Survival Outcomes From CheckMate 227: Nivo + Ipi…

ASCO 2022 Conference Coverage

L. Paz-Ares

146 views
01:21

Lecture Summary - ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L …

ASCO 2022 Conference Coverage

F. de Marinis

27 views
12:27

ASCO 2022 on the Phase 3 AcceleRET Lung Study: 1L Pralsetinib in RET…

ASCO 2022 Conference Coverage

F. de Marinis

182 views
01:08

Lecture Summary - Pralsetinib in Patients (pts) With Advanced or Met…

ASCO 2022 Conference Coverage

L. Wirth

20 views
10:01

ASCO 2022 Updated Data From the ARROW Trial: Pralsetinib in Patients…

ASCO 2022 Conference Coverage

L. Wirth

158 views
01:46

Lecture Summary - ASCO 2022 3-Year Update From CheckMate 9LA: 1L Niv…

ASCO 2022 Conference Coverage

L. Paz-Ares

21 views
09:18

ASCO 2022 3-Year Update From CheckMate 9LA: 1L Nivo + Ipi + 2 Cycles…

ASCO 2022 Conference Coverage

L. Paz-Ares

477 views
26:58

ASCO 2022 Immunotherapy Nuances in Locally Advanced NSCLC

ASCO 2022 Conference Coverage

J. Varlotto

31 views
48

Lecture Summary - ASCO 2022 Immunotherapy Nuances in Locally Advance…

ASCO 2022 Conference Coverage

J. Varlotto

23 views
06:33

ASCO 2022 on Acquired EGFR-Resistant Mutations in NSCLC

ASCO 2022 Conference Coverage

L. Raez

275 views
55

Lecture Summary - ASCO 2022 on Acquired EGFR-Resistant Mutations in …

ASCO 2022 Conference Coverage

L. Raez

14 views
01:06

Lecture Summary - ASCO 2022 on Recurrent SCLC: Can We Change the Par…

ASCO 2022 Conference Coverage

R. Gentzler

16 views
01:28

Lecture Summary - ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo i…

ASCO 2022 Conference Coverage

B. Chul Cho

14 views
07:37

ASCO 2022 on Durvalumab +/- Tremelimumab + Chemo in 1L mNSCLC: AE Ma…

ASCO 2022 Conference Coverage

B. Chul Cho

60 views
05:02

ASCO 2022 on IO and Chemo-IO for NSCLC With Novel Actionable Oncogen…

ASCO 2022 Conference Coverage

L. Mazzeo, M. Occhipinti

186 views
01:09

Lecture Summary - ASCO 2022 Impact of Trilaciclib on Multilineage Ch…

ASCO 2022 Conference Coverage

J. Goldschmidt

18 views
14:23

ASCO 2022 Impact of Trilaciclib on Multilineage Chemo-Induced Myelos…

ASCO 2022 Conference Coverage

J. Goldschmidt

92 views
04:31

ASCO 2022 Predictors of Biomarker Testing Among Pts With mNSCLC

ASCO 2022 Conference Coverage

N. Robert

691 views
06:43

ASCO 2022 on a Phase I, Open-Label, Dose Escalation, Confirmation, a…

ASCO 2022 Conference Coverage

J. Heymach

106 views
01:17

Lecture Summary - ASCO 2022 on a Phase I, Open-Label, Dose Escalatio…

ASCO 2022 Conference Coverage

J. Heymach

14 views
20:37

Taking on Goliath: Targeting KRAS in NSCLC

Jia Luo

1.2K views
07:03

ASCO 2022 on Phase 3 ATLANTIS Trial: Analysis of Patients With Relap…

ASCO 2022 Conference Coverage

A. Navarro

253 views
05:27

ASCO 2022 on Telisotuzumab Vedotin in Advanced c-Met Overexpressing …

ASCO 2022 Conference Coverage

R. Camidge

180 views
52

Lecture Summary - ASCO 2022 Analysis of Patients With Relapsed SCLC …

ASCO 2022 Conference Coverage

A. Navarro

23 views
23

Lecture Summary - ASCO 2022 on Telisotuzumab Vedotin in Advanced c-M…

ASCO 2022 Conference Coverage

R. Camidge

289 views
05:57

ASCO 2022 on TROPION-Lung08: Dato-DXd + Pembro in Treatment-Naïve Ad…

ASCO 2022 Conference Coverage

B. Levy

131 views
01:18

Lecture Summary - ASCO 2022 on ctDNA Shed as a Tool to Select Immune…

ASCO 2022 Conference Coverage

B. Besse

88 views
33

Lecture Summary - ASCO 2022 Combi-TED: A Multicenter Phase II Trial …

ASCO 2022 Conference Coverage

F. Cappuzzo

19 views
04:36

ASCO 2022 Combi-TED: A Multicenter Phase II Trial Evaluating Efficac…

ASCO 2022 Conference Coverage

F. Cappuzzo

64 views
01:01

Lecture Summary - ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in…

ASCO 2022 Conference Coverage

K. Gaebe

47 views
15:49

ASCO 2022 on Stereotactic Radiosurgery vs. WBRT in SCLC and Intracra…

ASCO 2022 Conference Coverage

K. Gaebe

431 views
25

Lecture Summary - ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Stud…

ASCO 2022 Conference Coverage

J. Sands

43 views
04:05

ASCO 2022 on KEYVIBE-008: Randomized, Phase 3 Study of 1L Vibostolim…

ASCO 2022 Conference Coverage

J. Sands

510 views
24

Lecture Summary - ASCO 2022 on Clinical and Genomic Characteristics …

ASCO 2022 Conference Coverage

J. Sands

20 views
07:37

ASCO 2022 on Clinical and Genomic Characteristics of Pts With Durabl…

ASCO 2022 Conference Coverage

J. Sands

278 views
52

Lecture Summary - ASCO 2022 Three-Year Outcomes and Correlative Anal…

ASCO 2022 Conference Coverage

B. Ricciuti

114 views
07:54

ASCO 2022 Three-Year Outcomes and Correlative Analyses in Patients W…

ASCO 2022 Conference Coverage

B. Ricciuti

319 views
07:00

ASCO 2022 on GEOMETRY-N Trial: Neoadjuvant and Adjuvant Capmatinib i…

ASCO 2022 Conference Coverage

J. Lee

961 views